Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 4.41987518 |
2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.14899542 |
3 | proteasome assembly (GO:0043248) | 4.14635341 |
4 | ATP synthesis coupled proton transport (GO:0015986) | 3.69963964 |
5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.69963964 |
6 | protein complex biogenesis (GO:0070271) | 3.69844883 |
7 | L-phenylalanine catabolic process (GO:0006559) | 3.69677890 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.69677890 |
9 | respiratory chain complex IV assembly (GO:0008535) | 3.65271918 |
10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.64171135 |
11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.60542022 |
12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.60542022 |
13 | NADH dehydrogenase complex assembly (GO:0010257) | 3.60542022 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.42454831 |
15 | L-phenylalanine metabolic process (GO:0006558) | 3.42454831 |
16 | respiratory electron transport chain (GO:0022904) | 3.41971737 |
17 | rRNA modification (GO:0000154) | 3.41340552 |
18 | electron transport chain (GO:0022900) | 3.36951738 |
19 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.36404864 |
20 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.32615049 |
21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.28870422 |
22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.18966001 |
23 | cytochrome complex assembly (GO:0017004) | 3.17956096 |
24 | platelet dense granule organization (GO:0060155) | 3.17921000 |
25 | chaperone-mediated protein transport (GO:0072321) | 3.12808522 |
26 | protein neddylation (GO:0045116) | 3.11290208 |
27 | immunoglobulin mediated immune response (GO:0016064) | 3.11000937 |
28 | pseudouridine synthesis (GO:0001522) | 3.09752462 |
29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.03315382 |
30 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.01406677 |
31 | cytidine metabolic process (GO:0046087) | 3.00220032 |
32 | cytidine catabolic process (GO:0006216) | 3.00220032 |
33 | cytidine deamination (GO:0009972) | 3.00220032 |
34 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.00151452 |
35 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.99794767 |
36 | metallo-sulfur cluster assembly (GO:0031163) | 2.95595441 |
37 | iron-sulfur cluster assembly (GO:0016226) | 2.95595441 |
38 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94944855 |
39 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.94568196 |
40 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.92471586 |
41 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.92471586 |
42 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.90874296 |
43 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.90874296 |
44 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.90874296 |
45 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.88647402 |
46 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.88647402 |
47 | neutrophil activation involved in immune response (GO:0002283) | 2.88044949 |
48 | aldehyde catabolic process (GO:0046185) | 2.87082209 |
49 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.86611891 |
50 | negative regulation of ligase activity (GO:0051352) | 2.86611891 |
51 | aromatic amino acid family catabolic process (GO:0009074) | 2.85463039 |
52 | termination of RNA polymerase III transcription (GO:0006386) | 2.82507530 |
53 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.82507530 |
54 | S-adenosylmethionine metabolic process (GO:0046500) | 2.80256226 |
55 | L-methionine salvage (GO:0071267) | 2.80176525 |
56 | L-methionine biosynthetic process (GO:0071265) | 2.80176525 |
57 | amino acid salvage (GO:0043102) | 2.80176525 |
58 | B cell mediated immunity (GO:0019724) | 2.79522380 |
59 | glyoxylate metabolic process (GO:0046487) | 2.78231991 |
60 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.77172158 |
61 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.77172158 |
62 | response to interferon-beta (GO:0035456) | 2.76415818 |
63 | xenobiotic catabolic process (GO:0042178) | 2.75231458 |
64 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74448660 |
65 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.70204450 |
66 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.69012824 |
67 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.68107288 |
68 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.66409195 |
69 | protein targeting to mitochondrion (GO:0006626) | 2.66003399 |
70 | deoxyribonucleotide catabolic process (GO:0009264) | 2.64331702 |
71 | deoxyribose phosphate catabolic process (GO:0046386) | 2.63597513 |
72 | aerobic respiration (GO:0009060) | 2.62383640 |
73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.62137421 |
74 | regulation of cellular amine metabolic process (GO:0033238) | 2.60412169 |
75 | regulation of mitochondrial translation (GO:0070129) | 2.59383850 |
76 | positive regulation of interleukin-17 production (GO:0032740) | 2.59155581 |
77 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.57681106 |
78 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.57359581 |
79 | peptidyl-histidine modification (GO:0018202) | 2.56798096 |
80 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.56470553 |
81 | ribosomal small subunit assembly (GO:0000028) | 2.54659097 |
82 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.53192357 |
83 | positive regulation of ligase activity (GO:0051351) | 2.52674632 |
84 | tetrahydrofolate metabolic process (GO:0046653) | 2.51185353 |
85 | viral mRNA export from host cell nucleus (GO:0046784) | 2.45628569 |
86 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.44985824 |
87 | hydrogen ion transmembrane transport (GO:1902600) | 2.44176513 |
88 | rRNA methylation (GO:0031167) | 2.43667299 |
89 | purine-containing compound salvage (GO:0043101) | 2.41900327 |
90 | establishment of protein localization to mitochondrion (GO:0072655) | 2.39134598 |
91 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.38899719 |
92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.35843067 |
93 | protein localization to mitochondrion (GO:0070585) | 2.35122373 |
94 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.29428238 |
95 | spliceosomal snRNP assembly (GO:0000387) | 2.28678679 |
96 | positive regulation of cell cycle arrest (GO:0071158) | 2.28182324 |
97 | base-excision repair, AP site formation (GO:0006285) | 2.27988030 |
98 | neutrophil activation (GO:0042119) | 2.27393856 |
99 | purine nucleotide salvage (GO:0032261) | 2.27135143 |
100 | regulation of activation of Janus kinase activity (GO:0010533) | 2.26725147 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.33532751 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.00536312 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40312515 |
4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.32964055 |
5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.20805705 |
6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.18475255 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.15963465 |
8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03153362 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73036713 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.70984772 |
11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.69699331 |
12 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.68272698 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67053455 |
14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.57069715 |
15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.49071910 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48686090 |
17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.40347867 |
18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.39009861 |
19 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.33716917 |
20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.23119760 |
21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.21864240 |
22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.15609075 |
23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.12463332 |
24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.08215365 |
25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04137193 |
26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03994060 |
27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.02416485 |
28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.95623916 |
29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94757746 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93041817 |
31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.85940771 |
32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.85067218 |
33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81224540 |
34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78604877 |
35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.74778590 |
36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67153296 |
37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57124670 |
38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.52011077 |
39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51343481 |
40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51056096 |
41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47523882 |
42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46450944 |
43 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45376386 |
44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45193151 |
45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45122191 |
46 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.44029692 |
47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42956257 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42321085 |
49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40505076 |
50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38170851 |
51 | MYB_26560356_Chip-Seq_TH2_Human | 1.36479630 |
52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36011959 |
53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35373235 |
54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34010157 |
55 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29573326 |
56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28486654 |
57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24621773 |
58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24414639 |
59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20551182 |
60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18358179 |
61 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18282274 |
62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13962590 |
63 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12175935 |
64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11763413 |
65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09608194 |
66 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08840380 |
67 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02909784 |
68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01174271 |
69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98830400 |
70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98769642 |
71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98460349 |
72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97588515 |
73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97588515 |
74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97495896 |
75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97148985 |
76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.97017485 |
77 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96468646 |
78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94299126 |
79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93585787 |
80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92893225 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92667944 |
82 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91978047 |
83 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91401575 |
84 | MYB_26560356_Chip-Seq_TH1_Human | 0.90452544 |
85 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87891897 |
86 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87332622 |
87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.87317596 |
88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87216852 |
89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.87081702 |
90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86490270 |
91 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85140513 |
92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85065437 |
93 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82033218 |
94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.81528351 |
95 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.81383362 |
96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80491075 |
97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79991677 |
98 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.78349334 |
99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.76692284 |
100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.76692284 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 3.31026409 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.19100279 |
3 | MP0001835_abnormal_antigen_presentation | 3.07995640 |
4 | MP0009785_altered_susceptibility_to | 2.83987840 |
5 | MP0003195_calcinosis | 2.75655755 |
6 | MP0005671_abnormal_response_to | 2.71142346 |
7 | MP0002138_abnormal_hepatobiliary_system | 2.69301598 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.67298638 |
9 | MP0009333_abnormal_splenocyte_physiolog | 2.40682887 |
10 | MP0005084_abnormal_gallbladder_morpholo | 2.32072435 |
11 | MP0003724_increased_susceptibility_to | 2.31575693 |
12 | MP0006036_abnormal_mitochondrial_physio | 2.16225446 |
13 | MP0005464_abnormal_platelet_physiology | 2.03708769 |
14 | MP0005000_abnormal_immune_tolerance | 2.00070375 |
15 | MP0002132_abnormal_respiratory_system | 1.99292048 |
16 | MP0002148_abnormal_hypersensitivity_rea | 1.94287867 |
17 | MP0005075_abnormal_melanosome_morpholog | 1.92941720 |
18 | MP0001800_abnormal_humoral_immune | 1.89273440 |
19 | MP0005025_abnormal_response_to | 1.89212676 |
20 | MP0002723_abnormal_immune_serum | 1.82467649 |
21 | MP0003186_abnormal_redox_activity | 1.82408636 |
22 | MP0001764_abnormal_homeostasis | 1.80426982 |
23 | MP0005085_abnormal_gallbladder_physiolo | 1.76624064 |
24 | MP0002419_abnormal_innate_immunity | 1.75061341 |
25 | MP0005360_urolithiasis | 1.69609655 |
26 | MP0002452_abnormal_antigen_presenting | 1.66118696 |
27 | MP0003436_decreased_susceptibility_to | 1.65975727 |
28 | MP0002420_abnormal_adaptive_immunity | 1.64522356 |
29 | MP0001819_abnormal_immune_cell | 1.62956684 |
30 | MP0005365_abnormal_bile_salt | 1.62608495 |
31 | MP0002396_abnormal_hematopoietic_system | 1.55415535 |
32 | MP0009697_abnormal_copulation | 1.52258129 |
33 | MP0008469_abnormal_protein_level | 1.51757170 |
34 | MP0003011_delayed_dark_adaptation | 1.50708192 |
35 | MP0000372_irregular_coat_pigmentation | 1.50693272 |
36 | MP0006035_abnormal_mitochondrial_morpho | 1.50488374 |
37 | MP0008058_abnormal_DNA_repair | 1.49713609 |
38 | MP0001790_abnormal_immune_system | 1.49381749 |
39 | MP0005387_immune_system_phenotype | 1.49381749 |
40 | MP0001845_abnormal_inflammatory_respons | 1.48429776 |
41 | MP0003252_abnormal_bile_duct | 1.47777262 |
42 | MP0002277_abnormal_respiratory_mucosa | 1.45779201 |
43 | MP0005332_abnormal_amino_acid | 1.44025658 |
44 | MP0009764_decreased_sensitivity_to | 1.43450845 |
45 | MP0006082_CNS_inflammation | 1.42388138 |
46 | MP0002398_abnormal_bone_marrow | 1.39477132 |
47 | MP0000685_abnormal_immune_system | 1.39465106 |
48 | MP0000689_abnormal_spleen_morphology | 1.37055274 |
49 | MP0003786_premature_aging | 1.36740053 |
50 | MP0005645_abnormal_hypothalamus_physiol | 1.35456891 |
51 | MP0000716_abnormal_immune_system | 1.35448786 |
52 | MP0005408_hypopigmentation | 1.31478522 |
53 | MP0005636_abnormal_mineral_homeostasis | 1.27659095 |
54 | MP0005319_abnormal_enzyme/_coenzyme | 1.26177580 |
55 | MP0008877_abnormal_DNA_methylation | 1.23390200 |
56 | MP0008872_abnormal_physiological_respon | 1.20695593 |
57 | MP0002429_abnormal_blood_cell | 1.19063337 |
58 | MP0002722_abnormal_immune_system | 1.18810484 |
59 | MP0002405_respiratory_system_inflammati | 1.17706636 |
60 | MP0003878_abnormal_ear_physiology | 1.15338793 |
61 | MP0005377_hearing/vestibular/ear_phenot | 1.15338793 |
62 | MP0010329_abnormal_lipoprotein_level | 1.13426258 |
63 | MP0004019_abnormal_vitamin_homeostasis | 1.12210565 |
64 | MP0008007_abnormal_cellular_replicative | 1.11448585 |
65 | MP0010094_abnormal_chromosome_stability | 1.10082173 |
66 | MP0003693_abnormal_embryo_hatching | 1.07308086 |
67 | MP0003638_abnormal_response/metabolism_ | 1.05533668 |
68 | MP0001666_abnormal_nutrient_absorption | 1.02720781 |
69 | MP0010155_abnormal_intestine_physiology | 1.01734604 |
70 | MP0002736_abnormal_nociception_after | 1.01693244 |
71 | MP0000609_abnormal_liver_physiology | 1.01133932 |
72 | MP0005379_endocrine/exocrine_gland_phen | 1.00879334 |
73 | MP0009763_increased_sensitivity_to | 1.00769256 |
74 | MP0003075_altered_response_to | 0.99942122 |
75 | MP0005551_abnormal_eye_electrophysiolog | 0.98061959 |
76 | MP0002006_tumorigenesis | 0.97761655 |
77 | MP0002876_abnormal_thyroid_physiology | 0.97067395 |
78 | MP0002166_altered_tumor_susceptibility | 0.96848730 |
79 | MP0003763_abnormal_thymus_physiology | 0.94768943 |
80 | MP0003718_maternal_effect | 0.94764521 |
81 | MP0004957_abnormal_blastocyst_morpholog | 0.90968183 |
82 | MP0003866_abnormal_defecation | 0.90762300 |
83 | MP0009643_abnormal_urine_homeostasis | 0.88776690 |
84 | MP0002163_abnormal_gland_morphology | 0.88020496 |
85 | MP0005410_abnormal_fertilization | 0.87283599 |
86 | MP0003191_abnormal_cellular_cholesterol | 0.87204943 |
87 | MP0002693_abnormal_pancreas_physiology | 0.86592900 |
88 | MP0006072_abnormal_retinal_apoptosis | 0.83235847 |
89 | MP0002837_dystrophic_cardiac_calcinosis | 0.83083727 |
90 | MP0010386_abnormal_urinary_bladder | 0.82776845 |
91 | MP0000703_abnormal_thymus_morphology | 0.82681048 |
92 | MP0002019_abnormal_tumor_incidence | 0.82520457 |
93 | MP0003111_abnormal_nucleus_morphology | 0.82048190 |
94 | MP0008995_early_reproductive_senescence | 0.81838635 |
95 | MP0003303_peritoneal_inflammation | 0.80258452 |
96 | MP0009765_abnormal_xenobiotic_induced | 0.77805306 |
97 | MP0009642_abnormal_blood_homeostasis | 0.77736019 |
98 | MP0008873_increased_physiological_sensi | 0.77720228 |
99 | MP0001919_abnormal_reproductive_system | 0.77518429 |
100 | MP0001529_abnormal_vocalization | 0.76973919 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 4.28535203 |
2 | Acute encephalopathy (HP:0006846) | 4.04103278 |
3 | Mitochondrial inheritance (HP:0001427) | 4.02637816 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.99559959 |
5 | Generalized aminoaciduria (HP:0002909) | 3.77760354 |
6 | Renal Fanconi syndrome (HP:0001994) | 3.74472654 |
7 | Increased CSF lactate (HP:0002490) | 3.68988261 |
8 | Hepatocellular necrosis (HP:0001404) | 3.67583835 |
9 | Progressive macrocephaly (HP:0004481) | 3.57755985 |
10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.37999283 |
11 | Hepatic necrosis (HP:0002605) | 3.37733931 |
12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.19770585 |
13 | Cerebral edema (HP:0002181) | 3.13325575 |
14 | Myositis (HP:0100614) | 2.95948148 |
15 | Optic neuritis (HP:0100653) | 2.85017064 |
16 | Retrobulbar optic neuritis (HP:0100654) | 2.85017064 |
17 | Reduced antithrombin III activity (HP:0001976) | 2.84667984 |
18 | Increased hepatocellular lipid droplets (HP:0006565) | 2.82151164 |
19 | Stomatitis (HP:0010280) | 2.72740044 |
20 | Increased serum lactate (HP:0002151) | 2.71194328 |
21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69627343 |
22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.63001941 |
23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.63001941 |
24 | Orchitis (HP:0100796) | 2.62731946 |
25 | Lipid accumulation in hepatocytes (HP:0006561) | 2.59266359 |
26 | Lactic acidosis (HP:0003128) | 2.57339469 |
27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56127265 |
28 | Methylmalonic acidemia (HP:0002912) | 2.53764171 |
29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.48698921 |
30 | Type I transferrin isoform profile (HP:0003642) | 2.44915938 |
31 | Abnormality of renal resorption (HP:0011038) | 2.41778922 |
32 | Lethargy (HP:0001254) | 2.40434417 |
33 | Glycosuria (HP:0003076) | 2.39157406 |
34 | Abnormality of urine glucose concentration (HP:0011016) | 2.39157406 |
35 | Encephalitis (HP:0002383) | 2.38649498 |
36 | Aplastic anemia (HP:0001915) | 2.38047206 |
37 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.37625869 |
38 | Microvesicular hepatic steatosis (HP:0001414) | 2.37127764 |
39 | Abnormality of methionine metabolism (HP:0010901) | 2.33354226 |
40 | Abnormality of serum amino acid levels (HP:0003112) | 2.32314116 |
41 | Panhypogammaglobulinemia (HP:0003139) | 2.29982553 |
42 | Optic disc pallor (HP:0000543) | 2.29159349 |
43 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.27894070 |
44 | Methylmalonic aciduria (HP:0012120) | 2.25414624 |
45 | Prolonged partial thromboplastin time (HP:0003645) | 2.23197656 |
46 | Exertional dyspnea (HP:0002875) | 2.20797332 |
47 | Hyperglycinemia (HP:0002154) | 2.20574078 |
48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20500868 |
49 | Anorexia (HP:0002039) | 2.19647873 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19513426 |
51 | Petechiae (HP:0000967) | 2.19296368 |
52 | Respiratory failure (HP:0002878) | 2.18478193 |
53 | Leukodystrophy (HP:0002415) | 2.14601143 |
54 | CNS demyelination (HP:0007305) | 2.14335313 |
55 | Abnormality of macrophages (HP:0004311) | 2.14274864 |
56 | Increased muscle lipid content (HP:0009058) | 2.11069113 |
57 | Decreased central vision (HP:0007663) | 2.10326632 |
58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10154400 |
59 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10154400 |
60 | Pancreatic cysts (HP:0001737) | 2.07398466 |
61 | Abnormal protein glycosylation (HP:0012346) | 2.07357674 |
62 | Abnormal glycosylation (HP:0012345) | 2.07357674 |
63 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.07357674 |
64 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.07357674 |
65 | Hypoproteinemia (HP:0003075) | 2.06600861 |
66 | Vacuolated lymphocytes (HP:0001922) | 2.03710390 |
67 | Exercise intolerance (HP:0003546) | 2.03039089 |
68 | Acute hepatic failure (HP:0006554) | 2.00172310 |
69 | Pancytopenia (HP:0001876) | 1.99613147 |
70 | Increased IgM level (HP:0003496) | 1.99406479 |
71 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95088871 |
72 | Hypophosphatemic rickets (HP:0004912) | 1.94777552 |
73 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94360098 |
74 | Obstructive lung disease (HP:0006536) | 1.94360098 |
75 | Recurrent abscess formation (HP:0002722) | 1.94152125 |
76 | Spontaneous abortion (HP:0005268) | 1.93137750 |
77 | Nausea (HP:0002018) | 1.93035403 |
78 | Meningitis (HP:0001287) | 1.92941838 |
79 | Hyperphosphaturia (HP:0003109) | 1.90377572 |
80 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.89842744 |
81 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89365366 |
82 | True hermaphroditism (HP:0010459) | 1.87982407 |
83 | Pancreatic fibrosis (HP:0100732) | 1.86440359 |
84 | Recurrent bacterial skin infections (HP:0005406) | 1.84991178 |
85 | Abnormal biliary tract physiology (HP:0012439) | 1.84475336 |
86 | Bile duct proliferation (HP:0001408) | 1.84475336 |
87 | IgG deficiency (HP:0004315) | 1.83516041 |
88 | Keratoconjunctivitis sicca (HP:0001097) | 1.83195890 |
89 | Neutropenia (HP:0001875) | 1.82795454 |
90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.82574366 |
91 | Gangrene (HP:0100758) | 1.82192437 |
92 | Increased serum ferritin (HP:0003281) | 1.80830931 |
93 | Agammaglobulinemia (HP:0004432) | 1.80794030 |
94 | Progressive neurologic deterioration (HP:0002344) | 1.80646898 |
95 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80618418 |
96 | Vasculitis (HP:0002633) | 1.80304821 |
97 | Gingival bleeding (HP:0000225) | 1.80237447 |
98 | Hypothermia (HP:0002045) | 1.79810984 |
99 | Keratoconjunctivitis (HP:0001096) | 1.79535315 |
100 | Tetany (HP:0001281) | 1.79311467 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST4 | 4.42024519 |
2 | VRK2 | 3.49723427 |
3 | MAP3K12 | 3.04571503 |
4 | ZAK | 3.02748219 |
5 | BUB1 | 2.62038764 |
6 | TXK | 2.56179993 |
7 | VRK1 | 2.46702325 |
8 | STK16 | 2.41845032 |
9 | TESK2 | 2.34467262 |
10 | NUAK1 | 2.20191685 |
11 | BCKDK | 2.08348065 |
12 | TAOK3 | 2.07976737 |
13 | NME2 | 1.79084460 |
14 | KIT | 1.66924533 |
15 | TNK2 | 1.63928368 |
16 | MAP4K1 | 1.61258342 |
17 | EIF2AK3 | 1.48910272 |
18 | KDR | 1.39261861 |
19 | TLK1 | 1.36981260 |
20 | BLK | 1.36894825 |
21 | BMPR2 | 1.33181903 |
22 | IKBKB | 1.31324536 |
23 | SCYL2 | 1.30904552 |
24 | IKBKE | 1.22995405 |
25 | IRAK4 | 1.21715303 |
26 | ADRBK2 | 1.21009301 |
27 | CDK19 | 1.20959243 |
28 | CSF1R | 1.19179149 |
29 | PIK3CG | 1.17669229 |
30 | MAP4K2 | 1.17470978 |
31 | FES | 1.17046287 |
32 | SIK3 | 1.16803909 |
33 | GRK1 | 1.15074288 |
34 | DAPK1 | 1.15036732 |
35 | TRIM28 | 1.14956660 |
36 | FRK | 1.12881030 |
37 | INSRR | 1.12810312 |
38 | MAP3K11 | 1.12378873 |
39 | JAK3 | 1.12278625 |
40 | RIPK4 | 1.10121939 |
41 | PBK | 1.06627688 |
42 | LYN | 1.04888411 |
43 | OXSR1 | 1.02001620 |
44 | GRK6 | 1.01869608 |
45 | SYK | 0.99786216 |
46 | PLK3 | 0.99149374 |
47 | PDK2 | 0.94069680 |
48 | NME1 | 0.91960302 |
49 | FLT3 | 0.88044769 |
50 | BTK | 0.86859359 |
51 | ZAP70 | 0.83841159 |
52 | MATK | 0.83006131 |
53 | TAF1 | 0.82838845 |
54 | PLK4 | 0.82328774 |
55 | TYK2 | 0.82175027 |
56 | WNK3 | 0.79841493 |
57 | MAP2K6 | 0.77835226 |
58 | MAP2K3 | 0.77740571 |
59 | TBK1 | 0.74244940 |
60 | TESK1 | 0.74242575 |
61 | EIF2AK1 | 0.74129054 |
62 | CSNK1G3 | 0.74111631 |
63 | PRKCQ | 0.71375153 |
64 | MAP3K3 | 0.70410722 |
65 | CSK | 0.69274450 |
66 | TEC | 0.68332071 |
67 | PIM2 | 0.67677830 |
68 | RPS6KA5 | 0.67101880 |
69 | MARK3 | 0.66570366 |
70 | MAP3K5 | 0.65554707 |
71 | LCK | 0.64119892 |
72 | ILK | 0.63208237 |
73 | DYRK2 | 0.61185154 |
74 | PIM1 | 0.60284276 |
75 | TSSK6 | 0.60266889 |
76 | IRAK3 | 0.59626464 |
77 | MAPKAPK3 | 0.58685594 |
78 | RPS6KB2 | 0.58470276 |
79 | HCK | 0.57499298 |
80 | BRSK2 | 0.57219385 |
81 | ITK | 0.56608364 |
82 | NEK1 | 0.55566075 |
83 | ABL2 | 0.52086133 |
84 | MYLK | 0.51394074 |
85 | CDC7 | 0.50180291 |
86 | DYRK3 | 0.49099542 |
87 | IRAK1 | 0.48689825 |
88 | CSNK1G1 | 0.48475324 |
89 | TRPM7 | 0.48069982 |
90 | PRKG2 | 0.44842577 |
91 | CSNK2A1 | 0.44631049 |
92 | CSNK1G2 | 0.44157575 |
93 | DAPK3 | 0.43877014 |
94 | PINK1 | 0.43445294 |
95 | PLK1 | 0.42739655 |
96 | LRRK2 | 0.42135693 |
97 | ATR | 0.42120374 |
98 | AURKA | 0.41958200 |
99 | STK10 | 0.41449277 |
100 | JAK2 | 0.41014446 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.14108788 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.13853987 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.59230481 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.21115759 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.14799582 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07615554 |
7 | * One carbon pool by folate_Homo sapiens_hsa00670 | 2.02204758 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90731392 |
9 | Protein export_Homo sapiens_hsa03060 | 1.89014276 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 1.81683244 |
11 | Asthma_Homo sapiens_hsa05310 | 1.80121322 |
12 | Homologous recombination_Homo sapiens_hsa03440 | 1.77520735 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76115134 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73379314 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73055576 |
16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67643855 |
17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62560101 |
18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59767925 |
19 | Mismatch repair_Homo sapiens_hsa03430 | 1.58131638 |
20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48927192 |
21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46641138 |
22 | DNA replication_Homo sapiens_hsa03030 | 1.46420052 |
23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43993826 |
24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43531247 |
25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43487481 |
26 | Peroxisome_Homo sapiens_hsa04146 | 1.40555207 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.39763777 |
28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37853463 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37785365 |
30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31899442 |
31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30110463 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29915830 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28672767 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24630157 |
35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23528953 |
36 | Base excision repair_Homo sapiens_hsa03410 | 1.23184141 |
37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20047855 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19045995 |
39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18802018 |
40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17294456 |
41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15718765 |
42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15625310 |
43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15391339 |
44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14565902 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14130975 |
46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10765361 |
47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09432362 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08208075 |
49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06336621 |
50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05554109 |
51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05107568 |
52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03879573 |
53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02177976 |
54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98322321 |
55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98106386 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97094611 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96605386 |
58 | RNA degradation_Homo sapiens_hsa03018 | 0.93969762 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92431360 |
60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91528087 |
61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.88957395 |
62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88843837 |
63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88334092 |
64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87990259 |
65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85701483 |
66 | Purine metabolism_Homo sapiens_hsa00230 | 0.85026161 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83960714 |
68 | Spliceosome_Homo sapiens_hsa03040 | 0.83357952 |
69 | RNA transport_Homo sapiens_hsa03013 | 0.81362629 |
70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78816455 |
71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76896828 |
72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74439244 |
73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.73841441 |
74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73162559 |
75 | Legionellosis_Homo sapiens_hsa05134 | 0.72140380 |
76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68809219 |
77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66129744 |
78 | Phototransduction_Homo sapiens_hsa04744 | 0.65225587 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64810177 |
80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64783431 |
81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62141985 |
82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61858402 |
83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61419144 |
84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60366112 |
85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59125879 |
86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58269879 |
87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57950636 |
88 | Tuberculosis_Homo sapiens_hsa05152 | 0.57217690 |
89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56235397 |
90 | Measles_Homo sapiens_hsa05162 | 0.55671838 |
91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55439286 |
92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55432696 |
93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53926360 |
94 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50691398 |
95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49022404 |
96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48688329 |
97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47362434 |
98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47285232 |
99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47042005 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46743124 |